Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1

FiltersClear all

Status

Recruiting1

Study type

Interventional1

Phase

Phase 21

Investigator

Anthony O. Ahmed1
Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6

Show all 50Show fewer

Shmuel Chen6
Christopher F Liu5
Conor Liston5
Daniel W Skupski5
Michael G Kaplitt5

Department

Psychiatry1

Condition

Cognitive Dysfunction1
Schizophrenia1

Intervention type

Device1
Behavioral1
Drug1
Other1

Sponsor type

Industry1

Start date

to

Anthony O. Ahmed×Device×Clear all

Showing 1–1 of 1 studySort:

RecruitingInterventional · Phase 2NCT06502964 ↗
Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment

Reem Z. Sharaiha5

Manish Ashwin Parikh4

Benjamin Samstein4

Abhishek Jaywant3

Christopher Lau3

David M. Otterburn3

Evelyn M. Horn3

Peter Connolly3

Seth H. Goldbarg3

Stephanie L. Mick3

Steven M Markowitz3

Anna Podolanczuk2

Jaikirshan Khatri2

Leonard N Girardi2

Mehraneh Dorna Jafari2

Rajesh Kumar Malik2

Shing Chiu Wong2

Timothy McClure2

Asad Riaz Siddiqi1

Adam D. Talenfeld1

Christopher Agrusa1

Cheguevara Afaneh1

Cora Sternberg1

David Leslie Carr-Locke1

Daniel Joseph Holzwanger1

David J Slotwiner1

Darshana M Dadhania1

Dmitriy N. Feldman1

Yuhei Kobayashi1

Anthony O. Ahmed

PI

Intervention: Drug: ALTO-101 · Device: ALTO-101 Transdermal Delivery System · Drug: Placebo · Device: Placebo Transdermal Delivery System
Dates: Jun 2024 – Feb 2026 (est.)
Sponsor: Alto Neuroscience

SchizophreniaCognitive Impairment